We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$106B
AUM Growth
+$3.62B
(+3.5%)
Cap. Flow
-$1.47B
Cap. Flow
% of AUM
-1.39%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
3,812
New
177
Increased
783
Reduced
2,146
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$743M |
| 2 |
APC
Anadarko Petroleum
APC
|
+$215M |
| 3 |
Chevron
CVX
|
+$189M |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$161M |
| 5 |
Meta Platforms (Facebook)
META
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$281M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$219M |
| 4 |
Eli Lilly
LLY
|
+$212M |
| 5 |
RTX Corp
RTX
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.44% |
| 2 | Healthcare | 15.11% |
| 3 | Industrials | 11.28% |
| 4 | Energy | 10.95% |
| 5 | Technology | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Bath & Body Works
BBWI
$4.01B
| $8.07M | 0.01% |
170,214
-3
| -0% | -$137 |
|
|
MJN
827
DELISTED
Mead Johnson Nutrition Company
MJN
| $8.05M | 0.01% |
86,354
-895,025
| -91% | -$78.3M |
|
|
XLRN
828
DELISTED
Acceleron Pharma
XLRN
| $8.04M | 0.01% |
236,743
+7,824
| +3% | +$262K |
|
829
H&R Block
HRB
$5.18B
| $8.01M | 0.01% |
239,046
+235,922
| +7,552% | +$7.02M |
|
830
Petrobras Class A
PBR.A
$107B
| $7.99M | 0.01% |
511,000
-5,000
| -1% | -$77.1K |
|
|
RSTI
831
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $7.99M | 0.01% |
332,413
-44,115
| -12% | -$1.02M |
|
832
ICICI Bank
IBN
$106B
| $7.99M | 0.01% |
880,715
-1,117,061
| -56% | -$9.61M |
|
|
OPLN
833
Openlane
OPLN
$4.17B
| $7.96M | 0.01% |
660,220
-133,717
| -17% | -$1.54M |
|
|
GOLD
834
DELISTED
Randgold Resources Ltd
GOLD
| $7.94M | 0.01% |
95,215
-2,030
| -2% | -$156K |
|
835
CoStar Group
CSGP
$11.3B
| $7.87M | 0.01% |
497,400
-104,670
| -17% | -$1.7M |
|
|
HBI
836
DELISTED
Hanesbrands
HBI
| $7.82M | 0.01% |
317,576
-369,460
| -54% | -$7.62M |
|
837
Brinker International
EAT
$8.02B
| $7.77M | 0.01% |
159,728
-4,900
| -3% | -$246K |
|
838
Phibro Animal Health
PAHC
$1.38B
| $7.76M | 0.01% |
+353,603
| New | +$6.72M |
|
|
IMS
839
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $7.76M | 0.01% |
+302,044
| New | +$7.26M |
|
|
AVTA
840
DELISTED
Avantax, Inc. Common Stock
AVTA
| $7.75M | 0.01% |
410,576
-11,091
| -3% | -$209K |
|
|
RLD
841
DELISTED
REALD INC COM STK
RLD
| $7.73M | 0.01% |
605,575
-217,659
| -26% | -$2.52M |
|
842
Enbridge
ENB
$124B
| $7.7M | 0.01% |
162,200
| – | – |
|
843
Commault Systems
CVLT
$5.89B
| $7.68M | 0.01% |
156,233
-3,983
| -2% | -$214K |
|
844
Spectrum Brands
SPB
$2.04B
| $7.68M | 0.01% |
89,252
-28,092
| -24% | -$2.19M |
|
845
Matrix Service
MTRX
$347M
| $7.65M | 0.01% |
233,255
+159,865
| +218% | +$5.28M |
|
846
Inogen
INGN
$167M
| $7.64M | 0.01% |
338,870
+33,597
| +11% | +$557K |
|
|
NEWP
847
DELISTED
NEWPORT CORP
NEWP
| $7.62M | 0.01% |
411,903
-6,830
| -2% | -$128K |
|
848
Core Laboratories
CLB
$538M
| $7.55M | 0.01% |
45,192
+4,808
| +12% | +$855K |
|
849
J.M. Smucker
SJM
$12.6B
| $7.54M | 0.01% |
70,780
-931
| -1% | -$93.5K |
|
850
Harmonic Inc
HLIT
$1.21B
| $7.5M | 0.01% |
1,005,255
-330,497
| -25% | -$2.38M |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, BlackRock Advisors held 3,812 positions worth $106B, up 3.5% from $102B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock Advisors's Q2 2014 filing shows 177 new, 783 increased, 2,146 reduced and 145 closed positions. Its largest new stake was iShares US Financials ETF: 3,120,594 shares worth $130M. The largest sale was Pfizer, an estimated $281M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.
- BlackRock Advisors's largest Q2 2014 buy was iShares US Financials ETF: 3,120,594 shares worth $130M.
- BlackRock Advisors added most to Apple in Q2 2014, an estimated $743M increase.
- BlackRock Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $281M.
- BlackRock Advisors fully exited PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS in Q2 2014, selling an estimated $40.9M.
- BlackRock Advisors's ten largest holdings make up 14% of its $106B portfolio in Q2 2014.
- BlackRock Advisors opened 177 new positions and closed 145 in Q2 2014.
- BlackRock Advisors's portfolio value rose 3.5% quarter-over-quarter to $106B.
Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.